Article Text

PDF
AB0718 Prevalence of risk factors for fractures in axial spondyloarthritis: a systematic review
  1. J García Ramírez1,
  2. R Curbelo2,
  3. JC Nieto3,
  4. S Castañeda4,
  5. L Carmona2
  1. 1Rheumatology, Hospital Clínic, Barcelona
  2. 2Instituto de Salud Músculoesquelética
  3. 3Rheumatology, Hospital G.U. Gregorio Marañόn
  4. 4Rheumatology, Hospital de la Princesa, Madrid, Spain

Abstract

Background Spinal fractures occur more than expected in axial spondyloarthritis (Ax-Sp). However, it is not totally clear whether fracture risk depends solely on biomechanical problems of the spondyloarthritic spine or whether the prevalence of risk factors for fracture is larger than expected in these patients.

Objectives To describe the prevalence of risk factors for osteoporotic fractures (both axial and peripheral) in Ax-Sp.

Methods A systematic literature search was conducted. Medline, Embase and Cochrane Library databases were searched with a sensitive strategy including type of study and synonyms of Ax-Sp. All contemporary cross sectional studies or baseline results from representative cohorts of Ax-Sp published between January 2006 and 2016 were selected for detailed review. Only studies that fulfilled a minimum quality for survey data were included. Data on bone mineral density, prevalence of osteoporosis, and risk factor for fractures in Ax-Sp patients were collected.

Results After screening 3597 titles and abstracts, only 43 studies (34 cross-sectional, 3 prospective and 6 retrospective) were reviewed in detail. Of these, 20 studies compared Ax-Sp patients with a control group, either healthy individuals (17 studies) or subjects with other diseases (6 studies). Reported prevalence of osteoporosis varied from 2% to 39.6%. Alcohol intake (58–61%), use of corticosteroids (11.7–67%), and 25-OH vitamin D deficit (26–76%) were unexpectedly high in Ax-Sp patients. All other factors were within expected frequencies for a not too old population.

Conclusions Our systematic review found that alcohol intake, steroid use and 25-OH-vitamin D deficit should be taken into account when assessing comorbidity in Ax-Sp in order to avoid excess fractures.

Acknowledgements this project was funded by Merck Sharp & Dohme of Spain.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.